Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9134 |
High Similarity |
NPD4625 |
Phase 3 |
0.8769 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8615 |
High Similarity |
NPD4908 |
Phase 1 |
0.8504 |
High Similarity |
NPD1610 |
Phase 2 |
0.8372 |
Intermediate Similarity |
NPD4749 |
Approved |
0.8333 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8321 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.8231 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.8209 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.8102 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.8062 |
Intermediate Similarity |
NPD4626 |
Approved |
0.806 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7985 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7956 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7956 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7908 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7903 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7895 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7887 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7846 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7801 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7801 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7761 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7756 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7717 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7714 |
Intermediate Similarity |
NPD1607 |
Approved |
0.771 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7698 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7686 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7669 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7669 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7652 |
Intermediate Similarity |
NPD2286 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7623 |
Intermediate Similarity |
NPD846 |
Approved |
0.7623 |
Intermediate Similarity |
NPD940 |
Approved |
0.7591 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7571 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7556 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7551 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7538 |
Intermediate Similarity |
NPD709 |
Approved |
0.7537 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7518 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD37 |
Approved |
0.75 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.748 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7468 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7451 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7448 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7429 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7426 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7426 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7426 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7405 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7403 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7385 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7385 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7383 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7383 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7383 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7372 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD3091 |
Approved |
0.7364 |
Intermediate Similarity |
NPD228 |
Approved |
0.7355 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7355 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7353 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7348 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7347 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7324 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7324 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD3020 |
Approved |
0.731 |
Intermediate Similarity |
NPD5408 |
Approved |
0.731 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD5404 |
Approved |
0.731 |
Intermediate Similarity |
NPD5405 |
Approved |
0.731 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7303 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7295 |
Intermediate Similarity |
NPD288 |
Approved |
0.7279 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7241 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD3748 |
Approved |
0.723 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7226 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7226 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7226 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7215 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7213 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7213 |
Intermediate Similarity |
NPD844 |
Approved |
0.7213 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7203 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7194 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD3226 |
Approved |
0.717 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD4059 |
Approved |
0.7132 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7131 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7131 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7109 |
Intermediate Similarity |
NPD968 |
Approved |
0.7105 |
Intermediate Similarity |
NPD4319 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7091 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7081 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7077 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7077 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7075 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7075 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7071 |
Intermediate Similarity |
NPD4339 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7068 |
Intermediate Similarity |
NPD497 |
Approved |
0.7063 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7059 |
Intermediate Similarity |
NPD4093 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7045 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7027 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7025 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD6815 |
Approved |
0.7007 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7007 |
Intermediate Similarity |
NPD3095 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7007 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7007 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7007 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5929 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7 |
Intermediate Similarity |
NPD2684 |
Approved |
0.6993 |
Remote Similarity |
NPD1512 |
Approved |
0.6993 |
Remote Similarity |
NPD7095 |
Approved |
0.6993 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6992 |
Remote Similarity |
NPD496 |
Approved |
0.6992 |
Remote Similarity |
NPD4869 |
Clinical (unspecified phase) |
0.6992 |
Remote Similarity |
NPD495 |
Approved |
0.6992 |
Remote Similarity |
NPD498 |
Approved |
0.6987 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD2157 |
Approved |
0.6984 |
Remote Similarity |
NPD289 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD4055 |
Discovery |
0.6981 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6972 |
Remote Similarity |
NPD5736 |
Approved |
0.6966 |
Remote Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD2531 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6959 |
Remote Similarity |
NPD4477 |
Approved |
0.6959 |
Remote Similarity |
NPD4476 |
Approved |
0.695 |
Remote Similarity |
NPD1470 |
Approved |
0.6944 |
Remote Similarity |
NPD7294 |
Phase 1 |
0.6944 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6939
|
Remote Similarity |
NPD4536 |
Approved |